# ProMIS Neurosciences, Inc. (PMN): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for ProMIS Neurosciences, Inc. (PMN) is 3/100, ranked against 25,000+ stocks in 38 markets (Quality 15, Value 35, Momentum 16, each scored against its sector).

- MoatMap Score: 3/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 15, Value 35, Momentum 16: each a 0-100 percentile within Healthcare.
- Position: #25,824 overall, #2,558 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 3.48 USD on 12 Nov 2026.
- Insider filings, last 180 days: directors bought USD 165K.

Source: https://moatmap.ai/stock/PMN
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker